Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?
World Journal of Urology · 2025
DOI: 10.1007/s00345-025-05988-5 ↗At a glance
Journal article in World Journal of Urology, 2025. Written by Louis Gobinet and 7 co-authors. Institution: Urology Department, CHU Bordeaux, Bordeaux, 33000, France. louis.gobinet@chu-bordeaux.fr. Major MEDLINE topics: Transurethral Resection of Bladder, Non-Muscle Invasive Bladder Neoplasms, Magnetic Resonance Imaging, Urinary Bladder Neoplasms. Cited 1 times so far (Crossref); 22 references.
Abstract (original language)
BACKGROUND AND OBJECTIVES: Repeat transurethral resection of bladder tumor (2nd -TURBT) is recommended for high-risk non-muscle invasive bladder cancer (HR-NMIBC) to reduce the risk of understaging and residual tumors. Despite its proven benefits, 2nd -TURBT remains an invasive and costly procedure. This study aimed to evaluate if bladder MRI, performed before initial TURBT (i-TURBT), could be in selected patient, a non-invasive alternative to 2nd -TURBT. METHODS: Data from 34 single-center patients who had MRI performed prior to i-TURBT and underwent 2nd -TURBT for HR-NMIBC between March 2020 and July 2024 were retrospectively collected. RESULTS: MpMRI demonstrated high accuracy in detecting muscle-invasive bladder cancer, with sensitivity, specificity, positive predictive value, and negative predictive value of 100% (95% CI 0.61-1), 96% (95% CI 0.82–0.99), 86% (95% CI 0.49–0.97), and 100% (95% CI 0.87-1), respectively. Among patients with mpMRI findings suggestive of NMIBC (n = 27), the residual tumor rate was 12% (n = 3). No residual tumor was found on 2nd-TURBT in patients with pTa tumor (n = 6) on i-TURBT and VIRADS ≤ 3, neither with pT1 tumor and detrusor muscle sampled on i-TURBT (n = 28), with unifocal VIRADS ≤ 3. CONCLUSION: Bladder MRI appears to be a valuable tool in HR-NMIBC management and could avoid 2nd -TURBT in selected patients, with a unifocal VIRADS ≤ 3 lesion and detrusor muscle sampled in i-TURBT.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Urology Department, CHU Bordeaux, Bordeaux, 33000, France. louis.gobinet@chu-bordeaux.fr.
- Urology Department, CHU Bordeaux, Bordeaux, 33000, France.
- Radiology Department, Institut Paoli-Calmettes, Marseille, 13009, France.
- Medical Oncology Department, Institut Paoli-Calmettes, Marseille, 13009, France.
- Department of Surgical Oncology 2, Institut Paoli-Calmettes, Marseille, 13009, France.
Cite
APA
Gobinet, L., Klein, C., Brunelle, S., Illy, M., Gravis, G., Walz, J., Branger, N., & Pignot, G. (2025). Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?. World Journal of Urology. https://doi.org/10.1007/s00345-025-05988-5
Vancouver
Gobinet L, Klein C, Brunelle S, Illy M, Gravis G, Walz J, et al. Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?. World Journal of Urology. 2025. doi:10.1007/s00345-025-05988-5
BibTeX
@article{Gobinet2025,
author = {Gobinet, Louis and Klein, Clément and Brunelle, Serge and Illy, Mathias and Gravis, Gwenaelle and Walz, Jochen and Branger, Nicolas and Pignot, Geraldine},
title = {Can bladder MRI avoid systematic second TURBT for patients with high-risk NMIBC?},
journal = {World Journal of Urology},
year = {2025},
doi = {10.1007/s00345-025-05988-5}
}
EUVIMED